You have 9 free searches left this month | for more free features.

nintedanib

Showing 51 - 75 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Fuenlabrada, Madrid (Nintedanib, Letrozole)

Completed
  • Breast Cancer
  • Fuenlabrada, Madrid, Spain
  • +2 more
Jul 22, 2019

Idiopathic Pulmonary Fibrosis, Lung Transplant; Complications Trial in Philadelphia (Nintedanib, Placebo Oral Tablet)

Unknown status
  • Idiopathic Pulmonary Fibrosis
  • Lung Transplant; Complications
  • Nintedanib
  • Placebo Oral Tablet
  • Philadelphia, Pennsylvania
    Temple University Hospital
Jul 8, 2019

Breast Cancer Trial in France (Docetaxel, Nintedanib, Docetaxel: increase of the dose)

Completed
  • Breast Cancer
  • Amiens, France
  • +11 more
May 29, 2019

NSCLC Trial in Chemnitz (Microgynon, Nintedanib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Chemnitz, Germany
    Klinikum Chemnitz gGmbH
Nov 22, 2018

Idiopathic Pulmonary Fibrosis Trial in United Kingdom (nintedanib, pirfenidone)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Bristol, United Kingdom
  • +8 more
Nov 5, 2018

Heathy Volunteer Trial in Daytona Beach (CC-90001, Omeprazole, Midazolam)

Completed
  • Heathy Volunteer
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Jan 24, 2019

Idiopathic Pulmonary Fibrosis Trial in Brazil (nintedanib)

No longer available
  • Idiopathic Pulmonary Fibrosis
  • nintedanib
  • Barra Mansa, Brazil
  • +7 more
Feb 7, 2019

Lung Diseases, Interstitial Trial in Worldwide (Nintedanib, Placebo)

Completed
  • Lung Diseases, Interstitial
  • Nintedanib
  • Placebo
  • Birmingham, Alabama
  • +152 more
Apr 22, 2020

Colorectal Tumors Trial in Fort Wayne (Nintedanib, Capecitabine)

Terminated
  • Colorectal Neoplasms
  • Fort Wayne, Indiana
    Fort Wayne Medical Oncology Hematology
Sep 12, 2018

NSCLC Trial in Japan (Nintedanib, Docetaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Chiba , Kashiwa, Japan
  • +5 more
Oct 4, 2018

Idiopathic Pulmonary Fibrosis Trial in Worldwide (nintedanib, )

Completed
  • Idiopathic Pulmonary Fibrosis
  • nintedanib
  • placebo
  • Jasper, Alabama
  • +85 more
Jul 16, 2019

Renal Cell Carcinoma, Colorectal Adenocarcinoma, Non-squamous NSCLC Trial in Birmingham (Nintedanib, Bevacizumab)

Completed
  • Renal Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
    University of Alabama at Birmingham Comprehensive Cancer Center
Jul 9, 2018

Scleroderma, Systemic Trial in Worldwide (Nintedanib, Placebo)

Completed
  • Scleroderma, Systemic
  • Nintedanib
  • Placebo
  • Birmingham, Alabama
  • +194 more
Nov 26, 2019

Idiopathic Pulmonary Fibrosis Trial in Worldwide (Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Jasper, Alabama
  • +172 more
Feb 28, 2022

Mesothelioma Trial in Worldwide (Nintedanib, Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Nintedanib
  • +3 more
  • Birmingham, Alabama
  • +122 more
Mar 15, 2019

Idiopathic Pulmonary Fibrosis Trial in Worldwide (Nintedanib, Placebo, Sildenafil)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • +2 more
  • Birmingham, Alabama
  • +84 more
Dec 17, 2018

Idiopathic Pulmonary Fibrosis Trial in Worldwide (Nintedanib, Pirfenidone)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Danbury, Connecticut
  • +22 more
Jan 17, 2018

Idiopathic Pulmonary Fibrosis Trial in Worldwide (Nintedanib, Pirfenidone)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Los Angeles, California
  • +37 more
May 16, 2018

Idiopathic Pulmonary Fibrosis Trial in Canada, Turkey, United States (Matching Placebo, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Matching Placebo
  • Nintedanib
  • Danbury, Connecticut
  • +24 more
Mar 19, 2018

Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemo for Metastatic Esophagogastric Cancer Trial (Nintedanib,

Withdrawn
  • Esophagogastric Adenocarcinoma
  • +2 more
  • Nintedanib
  • +4 more
  • (no location specified)
May 8, 2017

Healthy Trial in Biberach (Bosentan, Nintedanib)

Completed
  • Healthy
  • Biberach, Germany
    Boehringer Ingelheim Investigational Site
Mar 2, 2017

Idiopathic Pulmonary Fibrosis Trial in United States (nintedanib)

Approved for marketing
  • Idiopathic Pulmonary Fibrosis
  • nintedanib
  • Winter Park, Florida
  • +6 more
May 4, 2017

Recurrent NSCLC, Squamous Cell Lung Cancer, Stage III NSCLC Trial in Buffalo, Cleveland (nintedanib)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +3 more
  • nintedanib
  • Buffalo, New York
  • +1 more
May 10, 2017

Healthy Trial in Biberach (Nintedanib)

Completed
  • Healthy
  • Nintedanib
  • Biberach, Germany
    Boehringer Ingelheim Investigational Site
Nov 8, 2016

NSCLC Trial in Georgia, Thailand, United States (docetaxel, , nintedanib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Chandler, Arizona
  • +11 more
Feb 14, 2017